mSMART

Stratification for Myeloma And Risk-adapted Therapy

Our MISSION is to present the state of the art approach to management of these plasma cells disorders including myeloma, amyloidosis, and Waldenstroms Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence
          Mission
The mSMART Team!
Ansell, Stephen, M.D., Ph.D.
Lacy, Martha Q. M.D.
Bergsagel, Leif M.D.
Buadi, Francis K. M.D.
Dalton, Robert J. M.D.
Detweiler-Short, Kristen, N.P
Dingli, David M.D., Ph.D.
Dispenzieri, Angela M.D.
Fonseca, Rafael M.D.
Gertz, Morie A. M.D.
Greipp, Philip R. M.D.
Hayman, Suzanne R. M.D.
Kumar, Shaji M.D.
Lust, John A. M.D., Ph.D.
Mikhael, Joseph, M.D.
Nowakowski, Greg, M.D.
Rajkumar, S. Vincent. M.D.
Reeder, Craig B. M.D.
Roy, Vivek M. M.D.
Russell, Stephen J. M.D., Ph.D.
Stewart, Keith M.B.,Ch.B.
Witzig, Thomas E. M.D.
Zeldenrust, Steven R. M.D., Ph.D
Kyle, Robert A. M.D.